Literature DB >> 14709726

What now for aspirin and cancer prevention?

John A Baron.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14709726     DOI： 10.1093/jnci/djh027

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

1.  Structure-activity relationship study of novel anticancer aspirin-based compounds.

Authors:  Stancy Joseph; Ting Nie; Liqun Huang; Hui Zhou; Krishnaiah Atmakur; Ramesh C Gupta; Francis Johnson; Basil Rigas
Journal:  Mol Med Rep       Date:  2011-07-06       Impact factor: 2.952

2.  Phospho-sulindac (OXT-328), a novel sulindac derivative, is safe and effective in colon cancer prevention in mice.

Authors:  Gerardo G Mackenzie; Yu Sun; Liqun Huang; Gang Xie; Nengtai Ouyang; Ramesh C Gupta; Francis Johnson; Despina Komninou; Levy Kopelovich; Basil Rigas
Journal:  Gastroenterology       Date:  2010-06-20       Impact factor: 22.682

3.  Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.

Authors:  Liqun Huang; Gerardo G Mackenzie; Yu Sun; Nengtai Ouyang; Gang Xie; Kvetoslava Vrankova; Despina Komninou; Basil Rigas
Journal:  Cancer Res       Date:  2011-10-24       Impact factor: 12.701

4.  Phospho-Aspirin (MDC-22) Prevents Pancreatic Carcinogenesis in Mice.

Authors:  George Mattheolabakis; Ioannis Papayannis; Jennifer Yang; Brandon M Vaeth; Ruixue Wang; Jela Bandovic; Nengtai Ouyang; Basil Rigas; Gerardo G Mackenzie
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-02

5.  The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.

Authors:  Amy Hua; Gerardo G Mackenzie; Basil Rigas
Journal:  Int J Oncol       Date:  2009-10       Impact factor: 5.650

6.  Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effect.

Authors:  Liqun Huang; Chi C Wong; Ka W Cheng; Basil Rigas
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

7.  Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress.

Authors:  Liqun Huang; Chi C Wong; Gerardo G Mackenzie; Yu Sun; Ka Wing Cheng; Kvetoslava Vrankova; Ninche Alston; Nengtai Ouyang; Basil Rigas
Journal:  BMC Cancer       Date:  2014-02-28       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.